Upregulation of bone morphogenetic protein 4 is associated with poor prognosis in patients with hepatocellular carcinoma

Pathology and Oncology Research

Volumn 18, Issue 3, 2012, Pages 635-640

  Guo, Xiaodong ^a,b   Xiong, Lu ^b   Zou, Lin ^c   Zhao, Jingmin ^b  

^a MEDICAL SCHOOL OF CHINESE PLA   (China)

^b BEIJING 302 HOSPITAL   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Bone morphogenetic protein 4; Hepatocellular carcinoma; Prognosis

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTION; PROTEIN EXPRESSION; UNIVARIATE ANALYSIS; UPREGULATION;

ADULT; AGED; BONE MORPHOGENETIC PROTEIN 4; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84863990305     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-011-9488-2     Document Type: Article

References (29)

1. Yang H, Lin M, Xiong F, Yang Y, Nie X, McNutt MA, Zhou R (2011) Combined lysosomal protein transmembrane 4 beta-35 and argininosuccinate synthetase expression predicts clinical outcome in hepatocellular carcinoma patients. Surg Today 41:810-817
2. Farazi PA, DePinho RA (2006) Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 6:674-687
3. Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339-346
4. Chen D, Zhao M, Mundy GR (2004) Bone morphogenetic proteins. Growth Factors 22:233-241
5. Simic P, Vukicevic S (2005) Bone morphogenetic proteins in development and homeostasis of kidney. Cytokine Growth Factor Rev 16:299-308
6. Marki D, Celi T, Grkovi A, Spanjol J, Fukar Z, Grahovac B, Ethorevi G, Bobinac D (2011) mRNA expression of bone morphogenetic proteins and their receptors in human renal cell carcinoma. Urol Int In press
7. Yuen HF, Chan YP, Cheung WL, Wong YC, Wang X, Chan KW (2008) The prognostic significance of BMP-6 signaling in prostate cancer. Mod Pathol 21:1436-1443
8. Motoyama K, Tanaka F, Kosaka Y, Mimori K, Uetake H, Inoue H, Sugihara K, Mori M (2008) Clinical significance of BMP7 in human colorectal cancer. Ann Surg Oncol 15:1530-1537
9. Hogan BL (1996) Bone morphogenetic proteins in development. Curr Opin Genet Dev 6:432-438
10. Virtanen S, Alarmo EL, Sandstrom S, Ampuja M, Kallioniemi A (2011) Bone morphogenetic protein -4 and -5 in pancreatic cancer- novel bidirectional players. Exp Cell Res 317:2136-2146
11. McLean K, Gong Y, Choi Y, Deng N, Yang K, Bai S, Cabrera L, Keller E, McCauley L, Cho KR, Buckanovich RJ (2011) Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. J Clin Invest 121:3206-3219
12. Slattery ML, Lundgreen A, Herrick JS, Kadlubar S, Caan BJ, Potter JD, Wolff RK (2011) Genetic variation in bone morphogenetic protein and colon and rectal cancer. Int J Cancer In press
13. Qiao B, Johnson NW, Chen X, Li R, Tao Q, Gao J (2011) Disclosure of a stem cell phenotype in an oral squamous cell carcinoma cell line induced by BMP-4 via an epithelial-mesenchymal transition. Oncol Rep 26:455-461
14. Ketolainen JM, Alarmo EL, Tuominen VJ, Kallioniemi A (2010) Parallel inhibition of cell growth and induction of cell migration and invasion in breast cancer cells by bone morphogenetic protein. Breast Cancer Res Treat 124:377-386
15. Shon SK, Kim A, Kim JY, Kim KI, Yang Y, Lim JS (2009) Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells. Biochem Biophys Res Commun 385:198-203
16. Hjertner O, Hjorth-Hansen H, Borset M, Seidel C, Waage A, Sundan A (2001) Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 97:516-522
17. Maegdefrau U, Arndt S, Kivorski G, Hellerbrand C, Bosserhoff AK (2011) Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma. Lab Invest In press
18. Ishak KG, Anthony PP, Sobin LH (1994) Nonepithelial tumors. In: Ishak KG (ed) Histological typing of tumors of the liver. World Health Organization International Classification of Tumors. Springer, Berlin, pp 22-27
19. Wittekind C (2006) Pitfalls in the classification of liver tumors. Pathologe 27:289-293
20. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586-2593
21. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ (2008) High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 26:2707-2716
22. Shen H, Huang GJ, Gong YW (2003) Effect of transforming growth factor beta and bone morphogenetic proteins on rat hepatic stellate cell proliferation and trans-differentiation. World J Gastroenterol 9:784-787
23. Slattery ML, Lundgreen A, Herrick JS, Wolff RK, Caan BJ (2011) Genetic variation in the transforming growth factor-β signaling pathway and survival after diagnosis with colon and rectal cancer. Cancer 117:4175-4183
24. Lombardo Y, Scopelliti A, Cammareri P, Todaro M, Iovino F, Ricci-Vitiani L, Gulotta G, Dieli F, de Maria R, Stassi G (2011) Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Gastroenterology 140:297-309
25. LeeYC, ChengCJ, BilenMA, Lu JF, Satcher RL,Yu-Lee LY,Gallick GE,Maity SN, Lin SH(2011) BMP4 promotes prostate tumor growth in bone through osteogenesis. Cancer Res 71:5194-5203
26. Capasso M, Ayala F, Russo R, Avvisati RA, Asci R, Iolascon A (2009) A predicted functional single-nucleotide polymorphism of bone morphogenetic protein-4 gene affects mRNA expression and shows a significant associationwith cutaneousmelanoma in Southern Italian population. J Cancer Res Clin Oncol 135:1799-1807
27. Deng H, Ravikumar TS, Yang WL (2007) Bone morphogenetic protein-4 inhibits heat-induced apoptosis by modulating MAPK pathways in human colon cancer HCT116 cells. Cancer Lett 256:207-217
28. Hamada S, Satoh K, Hirota M, Fujibuchi W, Kanno A, Umino J, Ito H, Satoh A, Kikuta K, Kume K, Masamune A, Shimosegawa T (2009) Expression of the calcium-binding protein S100P is regulated by bone morphogenetic protein in pancreatic duct epithelial cell lines. Cancer Sci 100:103-110
29. Piccirillo SG, Reynolds BA, Zanetti N, Lamorte G, Binda E, Broggi G, Brem H, Olivi A, Dimeco F, Vescovi AL (2006) Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells. Nature 444:761-765